Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Insmed Inc shares valued at $647,200 were purchased by Wise John Drayton on Feb 06 ’25. At $80.90 per share, Wise John Drayton acquired 8,000 shares.
Also, Smith Michael Alexander purchased 21,000 shares, netting a total of over 1,698,900 in proceeds.
Before that, Schaeffer Orlov S Nicole had added 61,000 shares to its account. In a trade valued at $4,934,900, the Officer bought Insmed Inc shares for $80.90 each.
As published in their initiating research note from Truist on April 23, 2024, Insmed Inc [INSM] has been a Buy and the price target has been revised to $48. Analysts at Wolfe Research started covering the stock with ‘”an Outperform”‘ outlook in a report released in mid February. As of December 08, 2023, Wells Fargo has initiated its “an Overweight” rating for INSM.
Analyzing INSM Stock Performance
During the last five days, there has been a surge of approximately 5.89%. Over the course of the year, Insmed Inc shares have jumped approximately 17.00%. Shares of the company reached a 52-week high of $82.04 on 02/06/25 and a 52-week low of $61.50 on 01/10/25. A 50-day SMA is recorded $73.21, while a 200-day SMA reached $65.74. Nevertheless, trading volume fell to 2.49 million shares from 1.61 million shares the previous day.
Support And Resistance Levels for Insmed Inc (INSM)
According to the 24-hour chart, there is a support level at 80.16, which, if violated, would cause prices to drop to 79.54. In the upper region, resistance lies at 81.72. The next price resistance is at 82.66. RSI (Relative Strength Index) is 66.81 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 3.07, which suggests the price will increase in the coming days. Percent R is at 11.95%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
